Eric dEsparbes - May 15, 2022 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIOR)

Role
Chief Financial Officer
Signature
/s/ Will Pridgen, Attorney-in-Fact for Eric d'Esparbes
Stock symbol
BIOR
Transactions as of
May 15, 2022
Transactions value $
-$7,790
Form type
4
Date filed
5/17/2022, 05:18 PM
Previous filing
Apr 19, 2022
Next filing
Aug 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Tax liability -$7.79K -10.4K -2.45% $0.75 413K May 15, 2022 Direct F1
transaction BIOR Common Stock Award $0 +292K +70.84% $0.00 705K May 15, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOR Stock Option (Right to Buy) Award $0 +472K $0.00 472K May 15, 2022 Common Stock 472K $0.75 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 20,948 vested restricted stock units on May 15, 2022.
F2 Consists of 292,406 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.
F3 This option represents the right to purchase 472,495 shares of the Issuer's common stock, 9,843 of which vested upon grant, with the remaining shares vesting in equal monthly installments through April 15, 2026, subject to the Reporting Person's continued service to the Issuer.